Quick verdict
Tirzepatide for type 2 diabetes — and the most powerful A1c reducer available. Best for: Adults with type 2 diabetes who also want substantial weight loss.
Official site: Mounjaro.com · FDA prescribing label (PDF) · Savings program
Pros
- Best-in-class A1c reduction
- Significant weight loss as a side effect
- Same molecule as Zepbound
Cons
- Only labeled for type 2 diabetes
- Off-label use for weight loss not typically insured
- GI side effects
How Mounjaro works
Mounjaro contains tirzepatide, a dual receptor agonist that activates both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It mimics gut hormones released after eating, producing three core effects (see our deeper explainer on how GLP-1s work):
- Slowed gastric emptying — food stays in your stomach longer, increasing fullness.
- Reduced appetite signaling — the drug acts on the hypothalamus to suppress hunger and food noise.
- Glucose-dependent insulin release — pancreatic beta cells release insulin only when blood sugar is elevated, lowering A1c without typical hypoglycemia.
The additional GIP activity appears to enhance weight loss and improve insulin sensitivity beyond what GLP-1 alone achieves — likely why tirzepatide outperforms semaglutide in head-to-head trials.
Who Mounjaro is for
Adults with type 2 diabetes who also want substantial weight loss.
FDA-approved indications:
- Type 2 diabetes
Who should avoid it
- Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
- History of pancreatitis
- Severe gastroparesis or inflammatory bowel disease
- Pregnancy, planning pregnancy within 2 months, or breastfeeding
- Active gallbladder disease (relative contraindication)
See our full safety guide for context on each contraindication.
How to take Mounjaro
Starting dose: 2.5 mg weekly
Maximum dose: 15 mg weekly
- Inject subcutaneously in the abdomen, thigh, or upper arm.
- Once per week, same day each week, with or without food.
- Rotate injection sites to prevent skin irritation.
- Doses are titrated up monthly to minimize nausea — do not skip ahead.
Side effects
Common (≥5% of users):
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
Serious warnings:
- Boxed warning: thyroid C-cell tumors
- Pancreatitis
- Hypoglycemia with insulin
- Gallbladder disease
Most GI side effects appear during dose escalation and ease within 2–4 weeks. Eating smaller meals, avoiding greasy foods, and staying hydrated helps — our side-effect management guide covers practical tactics in detail. Persistent severe abdominal pain warrants immediate medical evaluation to rule out pancreatitis or gallbladder disease.
Where to get Mounjaro
- Primary care or endocrinology: The most reliable route — your clinician handles prior authorization and monitoring.
- Telehealth platforms: Services like Ro, WW Clinic (Sequence), Form Health, and Hims/Hers prescribe FDA-approved GLP-1s after a video evaluation. Verify they prescribe the brand name, not just compounded versions.
- Direct-to-consumer: Lilly Direct offers self-pay vials of Zepbound at reduced cash prices. See the official Mounjaro savings page.
- Avoid: Research peptides, unverified compounding pharmacies, and overseas online pharmacies. The FDA has documented counterfeit semaglutide circulating in the US supply chain.
Step-by-step pathways are covered in our guide to getting a GLP-1 prescription.
Cost
List price is approximately ~$1,069/mo. With commercial insurance and a savings card, many patients pay $0–$25/month. Without insurance, expect $500–$1,400/month depending on the program. Compare cash prices on GoodRx or Cost Plus Drugs.
Key evidence
The pivotal trial for Mounjaro is SURPASS-2 (NEJM, 2021): Tirzepatide outperformed semaglutide 1 mg on A1c reduction and weight loss in type 2 diabetes.
- FDA prescribing information (PDF) — full label, including boxed warning and trial summaries.
- ClinicalTrials.gov — active and completed studies of tirzepatide
- PubMed — peer-reviewed literature on tirzepatide
- ADA Standards of Care — pharmacologic approaches to glycemic treatment
Frequently asked questions
How quickly does Mounjaro work?
Most people notice reduced appetite within 1–2 weeks of starting Mounjaro. Meaningful weight or A1c changes typically appear after 8–12 weeks at a therapeutic dose, with maximum effects between 6 and 18 months.
Will I regain weight if I stop Mounjaro?
Clinical trials (STEP, SURMOUNT) show that most people regain a significant portion of lost weight within a year of stopping a GLP-1. These medications are generally considered long-term therapies, similar to blood pressure or cholesterol drugs.
Can I drink alcohol on Mounjaro?
There is no absolute contraindication, but alcohol can worsen nausea and increase the risk of pancreatitis and hypoglycemia (especially if combined with insulin or sulfonylureas). Many patients report decreased desire for alcohol on GLP-1s.
Is Mounjaro covered by insurance?
Coverage for type 2 diabetes is widespread under commercial plans and Medicare Part D. Prior authorization is common.
What happens if I miss a dose?
Take the missed dose within 5 days. If more than 5 days have passed, skip it and take the next scheduled dose. Do not double up.
Can I use Mounjaro during pregnancy?
No. GLP-1 medications should be stopped at least 2 months before a planned pregnancy. They are not recommended in pregnancy or breastfeeding due to limited safety data.
Compare Mounjaro to alternatives
Head-to-head guides: Mounjaro vs Ozempic. Or see the full side-by-side comparison table.
Zepbound
tirzepatide
The strongest FDA-approved weight-loss injection on the market.
Wegovy
semaglutide
Semaglutide for weight loss — the household name with cardiovascular data.
Ozempic
semaglutide
The semaglutide brand that started the GLP-1 revolution.
Further reading
- What are GLP-1 medications? — class overview
- How GLP-1s work in the body
- Are GLP-1s safe? — risks and contraindications
- Managing GLP-1 side effects
- How to get a prescription